Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:869065.
doi: 10.1155/2011/869065. Epub 2011 Dec 8.

Effect of Apheresis for ABO and HLA Desensitization on Anti-Measles Antibody Titers in Renal Transplantation

Affiliations

Effect of Apheresis for ABO and HLA Desensitization on Anti-Measles Antibody Titers in Renal Transplantation

Ulf Schönermarck et al. J Transplant. 2011.

Abstract

Desensitization strategies for ABO-incompatible renal transplants with plasma exchange (PE) or specific immunoadsorption (IA) decrease immunoglobulin levels. After recent measles outbreak and decreasing vaccination rates, we studied the impact of apheresis on anti-measles antibodies. Anti-measles antibodies were measured before desensitization, before transplantation and during followup in 12 patients with ABO incompatibility (2x PE only, 8x IA only, and 2x IA and PE) and 3 patients with donor-specific HLA antibodies (all PE). Patients received rituximab, IVIG, and standard immunosuppressive therapy. All patients had detectable anti-measles antibodies before desensitization (mean 3238 mU/l, range 560-8100). After 3-6 PE sessions, titers decreased significantly to 1710 mU/l (P < 0.05), in one patient to nondetectable values, while IA only maintained protective titers. After a median followup of 64 days, anti-measles antibodies returned to baseline in all patients. Immunity against measles was temporarily reduced by apheresis but remained detectable in most patients at time of transplantation. Desensitization maintains long-term protective immunity against measles.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of apheresis on reduction of anti-measles IgG antibodies. Antibody titer reduction (in %) at time of transplantation in comparison to the baseline values among patients using plasma exchange either alone or in combination with antigen-specific immunoadsorption (n = 7) or antigen-specific immunoadsorption alone (n = 8). There was a mean reduction of 40% in the plasma exchange group.
Figure 2
Figure 2
Effect of desensitization therapy on anti-measles IgG antibody titers (mU/l). Anti-measles antibodies were measured before desensitization therapy (“before”), the day before transplantation (“tx”) and during followup (“after”). Patients were analysed according to the used apheresis strategies: use of plasma exchange either alone or in combination with antigen-specific immunoadsorption (n = 7) or antigen-specific immunoadsorption alone (n = 8). At the time of transplantation, antibody titers were significantly reduced in the plasma exchange group compared to baseline (P < 0.05).

Similar articles

Cited by

References

    1. Flint SM, Walker RG, Hogan C, et al. Successful ABO-incompatible kidney transplantation with antibody removal and standard immunosuppression. American Journal of Transplantation. 2011;11(5):1016–1024. - PubMed
    1. Habicht A, Bröker V, Blume C, et al. Increase of infectious complications in ABO-incompatible kidney transplant recipients—a single centre experience. Nephrology Dialysis Transplantation. 2011;26(12):4124–4131. - PubMed
    1. Montgomery RA, Locke JE, King KE, et al. ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation. 2009;87(8):1246–1255. - PubMed
    1. Padmanabhan A, Ratner LE, Jhang JS, et al. Comparative outcome analysis of ABO-incompatible and positive crossmatch renal transplantation: a single-center experience. Transplantation. 2009;87(12):1889–1896. - PubMed
    1. Tobian AAR, Shirey RS, Montgomery RA, Ness PM, King KE. The critical role of plasmapheresis in ABO-incompatible renal transplantation. Transfusion. 2008;48(11):2453–2460. - PubMed